Skip to content



Ingenew Pharma Announces the Completion of the Hesperidin Virtual Clinical Trial in COVID-19 Subjects

Proof-of-concept of a virtual Phase 2 double-blind placebo-controlled clinical trial Hesperidin 1g daily reduced COVID-19 symptoms compared to placebo Montreal, December 22, 2021. Ingenew Pharma announces it has completed a

New Clinical Trial on Hesperidin

A natural product to fight symptoms related to COVID-19 The Montreal Heart Institute (MHI) is launching a new clinical trial to evaluate the effect of hesperidin on symptoms related to

Valeo Pharma Receives Hesperco(TM) Natural Product License Approval From Health Canada

HespercoTM capsules for immune system support to be commercially available by end of September 2020 HespercoTM pre-sales now available at online store   MONTREAL, QUEBEC , September 3, 2020 –

Ortho Regenerative Technologies Enters Into Licensing Agreement To Expand The Scope Of Its Technological Platform Applications

Montreal, QC, May 20, 2020 – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company”), an emerging orthobiologics company, today announced that it has entered into a strategic